Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

New UH study targets early signs of vision loss in diabetic patients

$3.3 million research could unlock early detection methods to prevent blindness
August 13, 2024
Diabetic Eye Disease
Translational Research
Grantee

A $3.3 million study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss. The study is being led by Wendy Harrison, associate professor, and is underwritten by the National Eye Institute.

Vision loss in type 2 diabetes results from diabetic retinopathy, caused by damage to blood vessels in the retina, the light-sensitive layer of tissue in the back of your eye. The disease can appear without warning.

Although patients with prediabetes are known to have impaired fasting glucose, impaired glucose tolerance, and elevated hemoglobin A1c, there is still a significant gap in understanding how and when prediabetes impacts eye health.

Harrison’s team will study both the front and the back of the eye and different types of glucose dysfunction. To explore how glucose dysregulation affects the vascular and neural retina, cornea, and tear film, the team will investigate whether tests like fat distribution, activity levels, and oral glucose tolerance in type 2 diabetes patients are linked to or can predict ocular health.